Determining the Efficacy of Neurofeedback Intervention on Anxiety and Stress Symptoms in Migraine Patients

This investigation aimed to determine the efficacy of neurofeedback intervention on stress and anxiety symptoms in migraine patients. The research method was quasi-experimental and descriptive, with a pre-test, post-test, and follow-up design, as well as experimental and control groups. The statistical cohort included all migraine patients who consulted psychological clinics in Tehran in 2018 and 2019. Thirty patients with scores one standard deviation above the mean were selected by convenience sampling and randomly assigned to the experimental and control groups from different institutions in Tehran province. Participants completed the Stress Resources and Stress Symptoms Questionnaire (SRSSQ) and Beck Anxiety Inventory (BAI for the pre-test, post-test, and follow-up. After 20 sessions of neurofeedback, the present study’s data were analyzed using the mixed design analysis of variance method and BioGraph Infiniti version 6 software. At the 0.01 significance level, it reduced physical symptoms (P<0.01, F=12.73), psychological/physical symptoms (P<0.01, F=8.87), behavioral symptoms (P<0.01, F=11.52), stress and anxiety (P<0.01, F=10.12). According to the results, neurofeedback may be used as a complementary treatment for patients with migraine and those with mental distress in order to reduce discomfort and acclimate to it more quickly and effectively